Literature DB >> 31551241

European drug agency approves cannabis-based medicine for severe forms of epilepsy.

Jacqui Wise1.   

Abstract

Entities:  

Year:  2019        PMID： 31551241     DOI： 10.1136/bmj.l5708

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Cannabidiol promotes apoptosis of osteosarcoma cells in vitro and in vivo by activating the SP1-CBX2 axis.

Authors:  Fangxing Xu; Guiyuan Sun; Zhibin Peng; Jingsong Liu; Zecheng Li; Jinglong Yan
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

2.  Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression.

Authors:  Zsolt Gáll; Szidónia Farkas; Ákos Albert; Elek Ferencz; Szende Vancea; Melinda Urkon; Melinda Kolcsár
Journal:  Biomolecules       Date:  2020-05-22

3.  Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.

Authors:  Szymon Hryhorowicz; Marta Kaczmarek-Ryś; Aleksandra Zielińska; Rodney J Scott; Ryszard Słomski; Andrzej Pławski
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

4.  Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy.

Authors:  Zsolt Gáll; Krisztina Kelemen; Andrea Tolokán; István Zolcseak; István Sável; Réka Bod; Elek Ferencz; Szende Vancea; Melinda Urkon; Melinda Kolcsár
Journal:  Biomedicines       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.